<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="../../external.html?link=http://www.w3.org/1999/xhtml"><head><title>Issues Berkeley Medical Journal</title>



  

  
  
  <meta http-equiv="content-language" content="English" />

  
  <meta name="description" content="ISSUES Berkeley Medical Journal--Berkeley undergraduate science, medicine, and health journalism." />

  
  <meta name="keywords" content="Issues, berkeley, university, california, journalism, science, medicine, undergraduate, journal, ISSUES Berkeley Medical Journal, Issues Berkeley" />

  
  <meta name="owner" content="ISSUES Berkeley Medical Journal" />

  
  <meta name="revisit-after" content="20 days" />

  
  <meta name="rating" content="General" />

  
  <meta name="robots" content="all" />

  
  <link rel="stylesheet" type="text/css" href="../style.css" /></head><body>
<div id="container">
<!--

******************************

	Header + Navigation

******************************

-->
<div id="header"><a href="../index.html"><img src="../images/logo.jpg" style="border: 0px solid ; float: left; width: 246px; height: 40px;" alt="" align="left" /></a></div>
<div id="nav">
<ul>
  <li><a href="contactus.html" title="Contact Us">Contact&nbsp;Us</a></li>
  <li><a href="archive.html" title="Publications">Archive</a></li>
  <li><a href="courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="aboutus.html" title="About Us">About&nbsp;Us</a></li>
  <li><a href="index.html" title="Home">Home</a></li>
</ul>
</div>
<!--

******************************

	News Updates Column

******************************

-->
<div id="newsupdate">
<h1>Links and Updates</h1>
<div class="newstitle">.site<span>Navigation*</span></div>
<div id="MainText-left">
<ul>
  <li><a href="index.html" title="Home">Home</a></li>
  <li><a href="aboutus.html" title="About Us">About Us</a></li>
  <li><a href="courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="archive.html" title="Publications">Archive</a></li>
  <li><a href="staff.html" title="Staff">Staff</a></li>
  <li><a href="joinus.html" title="Opportunities">Join Us<br />
    </a></li>
  <li><a href="advertise.html" title="Advertisements">Advertise</a></li>
  <li><a href="contactus.html" title="Contact Us">Contact Us</a></li>
</ul>
</div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div class="newstitle"><span><br />
</span></div>
<br />
<p><b><br />
<br />
</b></p>
<div class="newstitle"><span><b><br />
</b></span></div>
<b><br />
</b>
<p><b><b><br />
<br />
<br />
<a href="../../external.html?link=http://www.ocf.berkeley.edu/">
<br />
</a> </b></b></p>
</div>
<!--

******************************

   Welcome Message IMG+TEXT

******************************

-->
<div class="rightcontainer">
<div id="welcome"><b><b>science. medicine. health.</b></b></div>
<div id="content">
<p style="text-align: center;"><a href="15.2_Bai_D_Treating_HIV_1.html"><small><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;">return to
previous page</span></small></a></p>
<p style="text-align: center;"><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;"><a href="15.2_Issue.html"><small>return
to issue</small></a><br />
</span></p>
<p><br />
</p>
<p style="font-style: italic;"><small>continued from TREating HIV<br />
</small></p>
<p><small><br />
</small></p>
<p><small> &nbsp;&nbsp; Sarkar&#8217;s study focused on the genetic
engineering of Tre. To make this enzyme similar to Cre, the researchers
used directed evolution, a process similar to breeding. They sought a
certain mutation of Cre that showed activity for the HIV DNA sequence
and continued its replication to produce subsequent mutations until it
successfully excised the entire viral sequence from the host DNA. Tre
was found to show the most efficient recombination, or ability to cut
out the HIV DNA as well as ligate and anneal the host DNA. &#8220;It was
definitely a challenging task, as directed evolution of the recombinase
took over a year and a half, followed by meticulous screening and
selection,&#8221; says Joachim Hauber, PhD, Heinrich Petter Institute of
Virology.<br />
<br />
&nbsp;&nbsp;&nbsp; Tre specifically targets the integrated provirus, a
DNA copy of HIV integrated into the host DNA. Specifically, it
recognizes the asymmetric, or non-similar, viral sequence within the
host cell genome and efficiently excises it, mirroring Cre&#8217;s function
with the lox P sites. The cut DNA is then released from the cell body
and disposed of. With the viral DNA removed, the host cells no longer
produce the virus and thus do not rupture or propagate infection.<br />
<br />
&nbsp;&nbsp;&nbsp; This is not the first time the idea of directly
targeting the viral DNA has been suggested. Studies published in other
journals, such as the 2000 issue of Biochemical Cell Biology, have
reported that HIV-1 DNA flanked by lox P sites can be recognized and
cut by the Cre enzyme. The idea of using recombinase to excise HIV
viral DNA surfaced as early as 1997. Only now, however, has the idea
been successfully carried out in a successfully engineered enzyme. The
article itself concedes that an efficient and safe method of enzyme
delivery will be necessary, but difficult to develop. Still, Tre&#8217;s
success provides proof that the principle of attacking a retrovirus by
cutting it out of its infected genome is a realistic hypothesis.<br />
<br />
&nbsp;&nbsp;&nbsp; Despite the success of the enzyme, researchers are
still a long way off from providing a definite cure. In the June 2007
issue of Science, Alan Engelman, PhD, Harvard University, sees the
study as promising: &#8220;The results raise the possibility that customized
enzymes might someday help to eradicate HIV from the body,&#8221; but he adds
that much more work needs to be done in turning the enzyme into an
effective therapy. Even so, Sarkar&#8217;s reexamination of recombinase
techniques paves the way for new HIV DNA excision technologies.</small><br />
<br />
</p>
<p>
</p>
<h3><b><b><b><b>About the Author
</b></b></b></b></h3>
<p>
</p>
<p><small>David Bai is a third-year Integrative Biology major and hopes to one day work in the medical field.</small></p>
<p><br />
</p>
<p style="text-align: center;"><a href="15.2_Bai_D_Treating_HIV_1.html"><small>return to previous
page</small></a></p>
<p style="text-align: center;"><a href="15.2_Issue.html"><small>return
to issue</small></a><br />
</p>
<p style="text-align: center;"><br />
</p>
<div style="text-align: right;"><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;" /></div>
</div>
</div>
<div id="footer"> Copyright © 2008 ISSUES Berkeley Medical Journal |
Designed by MockUp | <a href="mailto:bmjwebm@gmail.com">Contact
Webmaster </a><br />
Not an official University publication. Content not necessarily
reflective of UC Berkeley or the ASUC.</div>
</div>

</body></html>